164 related articles for article (PubMed ID: 16800079)
1. [Quotidien prescription: between references and reality].
Verdoux H
Encephale; 2006 Jan; 32 Pt 2():S10-1. PubMed ID: 16800079
[No Abstract] [Full Text] [Related]
2. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].
Dassa D; Lacambre M; Vacheron MN
Encephale; 2009 Jan; Suppl 3():S109-13. PubMed ID: 19268179
[No Abstract] [Full Text] [Related]
3. [What should we recommend for schizophrenic patients: long-term drug prevention or interval treatment?].
Müller P
Nervenarzt; 1983 Sep; 54(9):477-85. PubMed ID: 6138720
[No Abstract] [Full Text] [Related]
4. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
Benoit M; Pon J; Zimmermann MA
Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
[No Abstract] [Full Text] [Related]
5. [Lifelong relapse prevention with antipsychotics in schizophrenia].
Hasan A; Wobrock T
Psychiatr Prax; 2010 Sep; 37(6):268-70. PubMed ID: 20803409
[No Abstract] [Full Text] [Related]
6. [CUtLASS 1 - Increasing disillusion about 2nd generation neuroleptics].
Steinert T
Psychiatr Prax; 2007 Jul; 34(5):255-7. PubMed ID: 17607643
[No Abstract] [Full Text] [Related]
7. Switching antipsychotic medications: a 2-year chart-review study exploring patient characteristics and psychiatric service use of schizophrenia patients.
Schneider AL; Mosier KE; Tempier RP
J Clin Psychiatry; 2009 Jun; 70(6):937-9. PubMed ID: 19573492
[No Abstract] [Full Text] [Related]
8. Algorithm for the treatment of negative symptoms in chronic schizophrenia.
Tsutsumi T; Uchimura H
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S15-7. PubMed ID: 10560892
[TBL] [Abstract][Full Text] [Related]
9. [Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia].
Fujii Y
Seishin Shinkeigaku Zasshi; 2001; 103(12):1030-5. PubMed ID: 11925840
[No Abstract] [Full Text] [Related]
10. [Longterm therapy of schizophrenia].
Pajonk FG; Wobrock T; Falkai P
Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
[No Abstract] [Full Text] [Related]
11. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
Canceil O; Limosin F; Passerieux C
Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
[No Abstract] [Full Text] [Related]
12. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
Buis C; Gourion D; Vaiva G
Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
[No Abstract] [Full Text] [Related]
14. Addition of antipsychotics to medication regimens during schizophrenic inpatient care.
Koyama A; Ito H; Nakanishi M; Sawamura K; Higuchi T
Psychiatry Clin Neurosci; 2008 Feb; 62(1):56-64. PubMed ID: 18289142
[TBL] [Abstract][Full Text] [Related]
15. Treatment challenges in the acute hospital setting.
Kasper S
World J Biol Psychiatry; 2005; 6(4):210-1. PubMed ID: 16272076
[No Abstract] [Full Text] [Related]
16. [Treatment of schizophrenia].
Bitter I
Orv Hetil; 2004 Jun; 145(24):1281-3. PubMed ID: 15264758
[No Abstract] [Full Text] [Related]
17. Long-term treatment with flupentixol results of a post-marketing surveillance study.
Messer T; Glaser T; Landen H; Schmauss M
J Psychopharmacol; 2009 Sep; 23(7):805-13. PubMed ID: 18562418
[TBL] [Abstract][Full Text] [Related]
18. [Is depot formulation a long-term optimal treatment option?].
Musch A
Med Monatsschr Pharm; 2005 Nov; 28(11):414-6. PubMed ID: 16309031
[No Abstract] [Full Text] [Related]
19. How multiple medication use evolves and the importance of therapeutic trials: the slippery slide.
Preskorn SH
J Psychiatr Pract; 2008 May; 14(3):170-5. PubMed ID: 18520787
[No Abstract] [Full Text] [Related]
20. Algorithm for treatment-refractory schizophrenia.
Koshino Y
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
